Lilly Beats Analyst Estimates on Diab...

Lilly Beats Analyst Estimates on Diabetes Drug Sales

There are 1 comment on the Bloomberg story from Oct 23, 2013, titled Lilly Beats Analyst Estimates on Diabetes Drug Sales. In it, Bloomberg reports that:

Eli Lilly & Co. , which may introduce five new drugs next year, reported third-quarter profit that beat analysts' estimates on cost cuts and higher sales of diabetes products.

Join the discussion below, or Read more at Bloomberg.

Jennette Peterson

Dothan, AL

#1 Oct 24, 2013
Can u please tell me when the medication CYMBALTA will be reduced in price ? I need this medication and the company I am trying to get a refill from which is Optm RX , they want to charge me $380,00 for 3 months and I am sorry I do not have this kind of money because I am on disabity /Medicare and their is no one living with me and no-one helping me Financially . Is there any way u can help me ? Please Right now I have only 1- 60 mg. capsule left and I need this medication deseperatly . my Dr. has prescribed it for me. Thank u for your time . Jennette Peterson My e-mail address is [email protected]

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Cancer Discussions

Title Updated Last By Comments
News Vienna: Family Fun Jam at Jammin Java Mon Cgl8017 1
News Why Suzanne Somers loves bioidentical hormones (Jun '09) Jul 27 Chaimpie 93
Itchy skin and fatigue - Help please :) Jul 27 Anonymous 1
LANGHAM CANCER RESEARCH @DERBY uk (Jul '13) Jul 24 andrew john langham 26
ESCOZUL is healing cancer patients (Mar '07) Jul '16 Anonymous 163
News Jerry Davich: Guys, time to talk frankly about ... (Aug '11) Jun '16 Joe2242 7
News VP Joe Biden Set for In-Depth Interview with NB... Jun '16 Teresa 3
More from around the web